Operationally, ophthalmology, a former division of Novartis, largely recovered from the pandemic-related setback in the third quarter. However, the company continues to write losses due to continued high extra costs.
—
Alcon has been groaning under a large mortgage since it was an independent company.
—
Alcon is the world market leader with its surgical equipment for the treatment of cataracts. The company, which once belonged to the Swiss pharmaceutical group Novartis, is also one of the largest suppliers of contact lenses. The third quarter figures presented on Wednesday underline that business in both areas has recovered to a considerable extent. From April to June, sales in the Surgical division almost halved compared to the previous year because eye operations had to be postponed due to the pandemic. Somewhat more unexpected was the one-third lower revenue at Vision Care.
–
